Analysts’ Viewpoint
Increasing R&D activities, technological advancements in toxicology drug testing, and rise in demand for toxicology drug testing in pharmaceuticals and biotechnology companies globally are estimated to boost the toxicology drug testing market outlook in the coming years. Emerging landscape post the COVID-19 pandemic led to shift in healthcare priorities and testing patterns. Demand for drug testing remained essential; however, the landscape underwent changes.
The pandemic spotlighted mental health and substance use issues, emphasizing the need for comprehensive drug testing. Innovations in remote and rapid testing gained traction, adapting to the evolving healthcare landscape. Telemedicine and digital platforms played pivotal roles in facilitating testing and result delivery. Moreover, regulatory adjustments and policy shifts shaped testing requirements and protocols. Laboratories and testing facilities adapted to new safety measures, ensuring accurate and secure sample collection and analysis.
Toxicology drug testing is a process that involves analyzing biological samples, such as urine, blood, saliva, or hair, to detect the presence of drugs or their metabolites. It is an essential tool used in various fields, including healthcare, workplace safety, forensic investigations, sports, addiction treatment, and pharmaceutical research. The toxicology drug testing market is poised for growth, which is estimated to offer significant opportunities for manufacturers to capitalize on this trend.
Technological advancements in toxicology drug testing, increasing R&D activities in pharmaceutical companies, and rise in demand for toxicology drug testing in pharmaceuticals and biotechnology companies across the globe are key factors driving the toxicology drug testing industry.
For instance, according to the IFPMA's 2021 study, the annual R&D expenditure of the biopharmaceutical business is 7.3 times more than that of the aerospace and defense industries; 6.5 times higher than that of the chemicals industry; and 1.5 times higher than that of the software and computer services industry. The aforementioned source also stated that the biopharmaceutical sector spend US$ 196,000 Mn in 2021, and US$ 213,000 Mn in 2024. Consequently, growth of the studied market is being fueled by rising R&D in the biopharmaceutical industry for the creation of pharmaceutical products.
The market under study is expanding as a result of recent technical advancements made by industry participants and researchers. For instance, CN Bio, an organ-on-a-chip (OOC) firm, introduced the PhysioMimix "in-a-box" reagent kit for non-alcoholic steatohepatitis (NASH) in April 2022. NASH is a condition for which there are currently no regulatory-approved therapies.
The PhysioMimix micro-physiological systems (MPS) from CN Bio and the NASH-in-a-box (NIAB) kit offer researchers the ability to get physiologically pertinent insights into the mechanism of disease, human therapeutic efficacy, and safety toxicity. These advancements are predicted to boost toxicology drug testing market expansion. However, longer time for sample testing and regulatory issues regarding approval of healthcare molecule are hampering market growth.
On the contrary, growing adoption of quality check products to prevent product recalls and growing demand for personalized medicine and precision toxicology are estimated to offer significant toxicology drug testing market opportunities during the forecast period.
Increasing prevalence of drug abuse and the need for workplace and clinical drug monitoring have been boosting the toxicology drug testing market value for the last few years. However, the COVID-19 pandemic has had a notable impact on this market.
The pandemic has led to a shift in healthcare priorities, with resources and focus primarily directed toward managing and containing the spread of the virus. Non-essential medical procedures, including drug testing, were temporarily put on hold, or reduced, in many healthcare settings. This led to a decline in the demand for toxicology drug testing during the pandemic.
Based on testing type, the in vitro segment accounted for largest global toxicology drug testing market share in 2022. This is attributed to rising use of in-vitro toxicology tests to determine skin toxicity, as they are simpler, more cost-effective, and more reliable than animal testing. Regulations enacted on toxicity assessment of cosmetics are also driving the demand for in-vitro dermal toxicity testing.
In terms of end-user, healthcare industry segment accounted for a notable share in 2022. Under healthcare segment, pharmaceutical & biotechnology companies segment further held a dominant market share. Toxicity testing is frequently used to examine the pharmacokinetic characteristics of pharmaceuticals. Toxicology testing requires assays for both new and generic medications. Toxicology assays are required in various fields including genotoxicity, safety pharmacology, absorption, distribution, metabolism, and excretion (ADME). Demand for in-vitro testing techniques is also estimated to increase due to the ongoing development and research for new pharmaceuticals as well as the candidate drug pipeline.
The diagnostics segment is estimated to expand at a rapid pace during the forecast due to rising number of diagnostic devices. The COVID-19 pandemic also pushed the diagnostic segment to develop innovative solutions for virus detection. Moreover, companies provide a comprehensive diagnostics product line for detection of therapeutic drug monitoring, long-term alcohol abuse, and point-of-care drug testing, thereby boosting the segment.
In terms of region, North America held a dominant market share of toxicology drug testing in 2022. This is attributed to the rise in demand for toxicological drug screening in pharmaceuticals and biotechnology in the region. Growing research and development (R&D) activities in the region are helping to detect toxicity levels in the human body at early stages.
Furthermore, the presence of a well-established pharmaceutical industry in the region, the high R&D expenditure, the strong presence of major service providers, and the growing trend of outsourcing analytical testing by pharmaceutical and biopharmaceutical companies in the region are major factors that are likely to positively influence the toxicology drug testing market outlook in the next few years.
As per the toxicology drug testing market forecast, Asia Pacific is expected to witness market expansion during the forecast period. This is ascribed to the rise of CROs, increase in consumer concern over product safety, and expansion of pharmaceutical drug pipeline in the region. Additionally, several countries in APAC are emerging as a lucrative hubs for drug development and clinical research due to their sizable potential pool, cost advantage, high participant, retention rate in clinical trial, and continually evolving regulatory framework.
The toxicology drug testing market report concludes with the company profiles section that includes key information about major players. Companies focus on strategies, such as new product launches, mergers, and partnerships & collaborations, to compete in the marketplace. Key toxicology drug testing companies include TDAL Labs, Thermo Fisher Scientific Inc., Abbott, Clinisys, Inc., Laboratory Corporation of America Holdings, SLUCARE, Icahn School of Medicine at Mount Sinai, Keystone Lab, Shimadzu Scientific Instruments, and Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
Key players in the toxicology drug testing market report have been profiled based on various parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
| Attribute | Details |
|---|---|
|
Size Value in 2022 |
US$ 34.7 Bn |
|
Forecast (Value) in 2031 |
More than US$ 55.7 Bn |
|
Compound Annual Growth Rate (CAGR) |
5.5% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 34.7 Bn in 2022.
It is projected to reach a value of around US$ 55.9 Bn by 2031.
The market is anticipated to grow at a CAGR of 5.5% from 2023 to 2031.
Increase in R&D activities, technological advancements in toxicology drug testing, and rise in demand for toxicology drug testing in pharmaceuticals and biotechnology companies
The in vitro segment accounted for largest share in 2022.
North America is expected to account for the largest share from 2023 to 2031.
TDAL Labs, Thermo Fisher Scientific Inc., Abbott, Clinisys, Inc., and Laboratory Corporation of America Holdings.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Toxicology Drug Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Toxicology Drug Testing Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Testing Type, 2017-2031
6.3.1. In Vitro
6.3.2. In Vivo
6.3.3. In Silico
6.4. Market Attractiveness Analysis, by Testing Type
7. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Method
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Testing Method, 2017-2031
7.3.1. Mass Spectrometry Imaging
7.3.2. Electron Microscopy
7.3.3. Fluorescence Labeling
7.3.4. Immunohistochemistry
7.3.5. Others
7.4. Market Attractiveness Analysis, by Testing Method
8. Global Toxicology Drug Testing Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Drug Development
8.3.2. Substance Abuse and Addiction
8.3.3. Therapeutic Drug Monitoring
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Toxicology Drug Testing Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Cosmetics Industry
9.3.2. Healthcare Industry
9.3.2.1. Hospital and Clinics
9.3.2.2. Diagnostic Laboratories
9.3.2.3. Pharmaceutical & Biotechnology Companies
9.3.2.4. Others
9.3.3. Food Industry
9.3.4. Chemicals Industry
9.4. Market Attractiveness Analysis, by End-user
10. Global Toxicology Drug Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Toxicology Drug Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Testing Type, 2017-2031
11.2.1. In Vitro
11.2.2. In Vivo
11.2.3. In Silico
11.3. Market Value Forecast, by Testing Method, 2017-2031
11.3.1. Mass Spectrometry Imaging
11.3.2. Electron Microscopy
11.3.3. Fluorescence Labeling
11.3.4. Immunohistochemistry
11.3.5. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Drug Development
11.4.2. Substance Abuse and Addiction
11.4.3. Therapeutic Drug Monitoring
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Cosmetics Industry
11.5.2. Healthcare Industry
11.5.2.1. Hospital and Clinics
11.5.2.2. Diagnostic Laboratories
11.5.2.3. Pharmaceutical & Biotechnology Companies
11.5.2.4. Others
11.5.3. Food Industry
11.5.4. Chemicals Industry
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Testing Type
11.7.2. By Testing Method
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Toxicology Drug Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Testing Type, 2017-2031
12.2.1. In Vitro
12.2.2. In Vivo
12.2.3. In Silico
12.3. Market Value Forecast, by Testing Method, 2017-2031
12.3.1. Mass Spectrometry Imaging
12.3.2. Electron Microscopy
12.3.3. Fluorescence Labeling
12.3.4. Immunohistochemistry
12.3.5. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Drug Development
12.4.2. Substance Abuse and Addiction
12.4.3. Therapeutic Drug Monitoring
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Cosmetics Industry
12.5.2. Healthcare Industry
12.5.2.1. Hospital and Clinics
12.5.2.2. Diagnostic Laboratories
12.5.2.3. Pharmaceutical & Biotechnology Companies
12.5.2.4. Others
12.5.3. Food Industry
12.5.4. Chemicals Industry
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Testing Type
12.7.2. By Testing Method
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Toxicology Drug Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Testing Type, 2017-2031
13.2.1. In Vitro
13.2.2. In Vivo
13.2.3. In Silico
13.3. Market Value Forecast, by Testing Method, 2017-2031
13.3.1. Mass Spectrometry Imaging
13.3.2. Electron Microscopy
13.3.3. Fluorescence Labeling
13.3.4. Immunohistochemistry
13.3.5. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Drug Development
13.4.2. Substance Abuse and Addiction
13.4.3. Therapeutic Drug Monitoring
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Cosmetics Industry
13.5.2. Healthcare Industry
13.5.2.1. Hospital and Clinics
13.5.2.2. Diagnostic Laboratories
13.5.2.3. Pharmaceutical & Biotechnology Companies
13.5.2.4. Others
13.5.3. Food Industry
13.5.4. Chemicals Industry
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Testing Type
13.7.2. By Testing Method
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Toxicology Drug Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Testing Type, 2017-2031
14.2.1. In Vitro
14.2.2. In Vivo
14.2.3. In Silico
14.3. Market Value Forecast, by Testing Method, 2017-2031
14.3.1. Mass Spectrometry Imaging
14.3.2. Electron Microscopy
14.3.3. Fluorescence Labeling
14.3.4. Immunohistochemistry
14.3.5. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Drug Development
14.4.2. Substance Abuse and Addiction
14.4.3. Therapeutic Drug Monitoring
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Cosmetics Industry
14.5.2. Healthcare Industry
14.5.2.1. Hospital and Clinics
14.5.2.2. Diagnostic Laboratories
14.5.2.3. Pharmaceutical & Biotechnology Companies
14.5.2.4. Others
14.5.3. Food Industry
14.5.4. Chemicals Industry
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Testing Type
14.7.2. By Testing Method
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Toxicology Drug Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Testing Type, 2017-2031
15.2.1. In Vitro
15.2.2. In Vivo
15.2.3. In Silico
15.3. Market Value Forecast, by Testing Method, 2017-2031
15.3.1. Mass Spectrometry Imaging
15.3.2. Electron Microscopy
15.3.3. Fluorescence Labeling
15.3.4. Immunohistochemistry
15.3.5. Others
15.4. Market Value Forecast, by End-user, 2017-2031
15.4.1. Drug Development
15.4.2. Substance Abuse and Addiction
15.4.3. Therapeutic Drug Monitoring
15.4.4. Others
15.5. Market Value Forecast, by Application, 2017-2031
15.5.1. Cosmetics Industry
15.5.2. Healthcare Industry
15.5.2.1. Hospital and Clinics
15.5.2.2. Diagnostic Laboratories
15.5.2.3. Pharmaceutical & Biotechnology Companies
15.5.2.4. Others
15.5.3. Food Industry
15.5.4. Chemicals Industry
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Testing Type
15.7.2. By Testing Method
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. TDAL Labs
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Abbott
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Icahn School of Medicine at Mount Sinai
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Clinisys, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Laboratory Corporation of America Holdings
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. SLUCARE
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Keystone Lab
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Shimadzu Scientific Instruments
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Other Players
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 02: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 03: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 06: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 08: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 09: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 12: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 13: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 14: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 15: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 18: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 19: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 20: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 21: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 22: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 23: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 24: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 25: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 26: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 27: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 28: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 29: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 30: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 31: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
Table 32: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
Table 33: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 34: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 35: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
Table 36: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 03: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 04: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vitro, 2017-2031
Figure 05: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vivo, 2017-2031
Figure 06: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Silico, 2017-2031
Figure 07: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 08: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 09: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Mass Spectrometry Imaging, 2017-2031
Figure 10: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Electron Microscopy, 2017-2031
Figure 11: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Fluorescence Labeling, 2017-2031
Figure 12: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Immunohistochemistry, 2017-2031
Figure 13: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
Figure 14: Global Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 15: Global Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 16: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Drug Development, 2017-2031
Figure 17: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Substance Abuse and Addiction, 2017-2031
Figure 18: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Therapeutic Drug Monitoring, 2017-2031
Figure 19: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
Figure 20: Global Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 21: Global Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 22: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Cosmetics Industry, 2017-2031
Figure 23: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Healthcare Industry, 2017-2031
Figure 24: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Food Industry, 2017-2031
Figure 25: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Chemicals Industry, 2017-2031
Figure 26: Global Toxicology Drug Testing Market Value Share Analysis, by Region, 2022 and 2031
Figure 27: Global Toxicology Drug Testing Market Attractiveness Analysis, by Region, 2023-2031
Figure 28: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 29: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 30: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 31: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 32: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 33: North America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 34: North America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 35: North America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 36: North America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 37: North America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 38: North America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 39: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 40: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 41: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 42: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 43: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 44: Europe Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 45: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 46: Europe Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Europe Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 48: Europe Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 49: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 50: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 51: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 52: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 53: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 54: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 55: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 56: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 57: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 58: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 59: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 60: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 61: Asia-Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 63: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 64: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 65: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 66: Latin America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 67: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 68: Latin America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 69: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 70: Latin America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 71: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 72: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 73: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
Figure 74: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
Figure 75: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
Figure 76: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
Figure 77: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 78: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 79: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 80: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
Figure 81: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 82: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
Figure 83: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Toxicology Drug Testing Market
*86 figures and 60 tables includes